Health
Novel antiviral drug candidate blocks SARS-CoV-2 reproduction in cells – Drug Target Review
In human cell assays, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
Posted: 16 September 2020 | Victoria Rees (Drug Target Review) | No comments yet
In human cells, a drug candidate called PF-00835231 has demonstrated success at blocking the reproduction of SARS-CoV-2.
A study in human cells found that an antiviral drug candidate called PF-00835231 may be at least as potent as the drug remdesivir at blocking the reproduction of SARS-CoV-2, which causes COVID-19.
PF-00835231 was shown in preliminary research in cells – conducted by New York University Grossman…
-
Noosa News21 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business24 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News23 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General22 hours agoInternal Revenue Service starts cutting 20,000 workers